CDCP1 and cancer: Upon exploration of CD318 interactions with immune proteins, we found that CD96 and CD160 might be interacting with CD318 in COAD cancer, leading to the accumulation of CD8+ T Cells and CD56dim highly cytotoxic NK cells in the tumor microenvironment.